[Expert opinion. Spironolactone: a new twist on an old story]
| Autor: | Yu L Begrambekova, Ya A Orlova, A. G. Plisuk |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) business.industry SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 Context (language use) Spironolactone chemistry.chemical_compound Mineralocorticoid receptor chemistry Expert opinion Hypertension medicine Humans Cardiology and Cardiovascular Medicine Intensive care medicine business Expert Testimony Mineralocorticoid Receptor Antagonists |
| Zdroj: | Kardiologiia. 61(10) |
| ISSN: | 0022-9040 |
| Popis: | The article presents recent data on possibilities of a broader use of mineralocorticoid receptor antagonists for existing indications and of expanding indications for the use of this pharmaceutical group in the context of the novel coronavirus infection COVID-19. The authors discussed prospects for expanded detection of aldosteronism using a new diagnostic approach, including an additional evaluation of blood pressure response to spironolactone. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|